Wilson FR - Search Results

1

Alveolar hydatid disease. Review of the surgical experience in 42 cases of active disease among Alaskan Eskimos.

Wilson JF, Rausch RL, Wilson FR. Wilson JF, et al. Among authors: wilson fr. Ann Surg. 1995 Mar;221(3):315-23. doi: 10.1097/00000658-199503000-00015. Ann Surg. 1995. PMID: 7717785 Free PMC article.

2

Immunological parameters associated with susceptibility or resistance to alveolar hydatid disease in Yupiks/Inupiats.

Gottstein B, Bettens F, Parkinson AJ, Wilson F. Gottstein B, et al. Arctic Med Res. 1996 Jan;55(1):14-9. Arctic Med Res. 1996. PMID: 8901163

3

Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer.

Keeping ST, Cope S, Chan K, Wilson FR, Jansen JP, Penrod JR, Abraham P, Camidge DR, Korytowsky B, Gu T, Garcia AJ, Le TK, Yuan Y. Keeping ST, et al. Among authors: wilson fr. J Comp Eff Res. 2020 Dec;9(18):1275-1284. doi: 10.2217/cer-2020-0134. Epub 2020 Nov 3. J Comp Eff Res. 2020. PMID: 33140652 Free article.

4

Treatment sequence network meta-analysis in Crohn's disease: a methodological case study.

Varu A, Wilson FR, Dyrda P, Hazel M, Hutton B, Cameron C. Varu A, et al. Among authors: wilson fr. Curr Med Res Opin. 2019 May;35(5):733-756. doi: 10.1080/03007995.2019.1580094. Epub 2019 Mar 20. Curr Med Res Opin. 2019. PMID: 30727745

5

Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis.

Wilson FR, Coombes ME, Brezden-Masley C, Yurchenko M, Wylie Q, Douma R, Varu A, Hutton B, Skidmore B, Cameron C. Wilson FR, et al. Syst Rev. 2018 Nov 14;7(1):191. doi: 10.1186/s13643-018-0854-y. Syst Rev. 2018. PMID: 30428932 Free PMC article.

6

Prospective Bundled Payments in a Changing Environment: The Experience of a Self-Funded, State-Sponsored Plan.

Lawler FH, Wilson FR, Smith GK, Mitchell LV. Lawler FH, et al. Among authors: wilson fr. Am Health Drug Benefits. 2017 Dec;10(9):441-447. Am Health Drug Benefits. 2017. PMID: 29403570 Free PMC article.

7

Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis.

Wilson FR, Coombes ME, Wylie Q, Yurchenko M, Brezden-Masley C, Hutton B, Skidmore B, Cameron C. Wilson FR, et al. Syst Rev. 2017 Oct 10;6(1):196. doi: 10.1186/s13643-017-0588-2. Syst Rev. 2017. PMID: 29017563 Free PMC article.

8

Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer.

Wilson FR, Varu A, Mitra D, Cameron C, Iyer S. Wilson FR, et al. Breast Cancer Res Treat. 2017 Nov;166(1):167-177. doi: 10.1007/s10549-017-4404-4. Epub 2017 Jul 27. Breast Cancer Res Treat. 2017. PMID: 28752187 Free PMC article. Review.

9

The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis.

Cameron C, Ewara E, Wilson FR, Varu A, Dyrda P, Hutton B, Ingham M. Cameron C, et al. Among authors: wilson fr. Med Decis Making. 2017 Nov;37(8):894-904. doi: 10.1177/0272989X17711933. Epub 2017 Jun 16. Med Decis Making. 2017. PMID: 28622083 Free article.

10

TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.

Ho A, Wilson FR, Peragine SL, Jeyanthan K, Mitchell TR, Zhu XD. Ho A, et al. Among authors: wilson fr. Sci Rep. 2016 Nov 14;6:36913. doi: 10.1038/srep36913. Sci Rep. 2016. PMID: 27841304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results